Dexcom has issued a Class I recall for its G6 Android app due to crashes that could cause users to miss critical glucose ...

Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP ("BLB&G") filed a class action in the U.S. District Court for the Southern District of New York alleging violations ...

What Happened? A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as ...

This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system.

Full study: “ A smart cup for wireless, biofuel-powered, sweat-based vitamin C sensing .” Co-authors of the study include Muhammad Inam Khan*, Ryan Burns*, Akshit Agarwal, Lu Yin, Jongmin Moon, Bumsik ...

DexCom's growth rate has been improving, but that hasn't been enough of a reason for investors to buy up the stock.

Morgan Stanley lowered the firm’s price target on DexCom (DXCM) to $63 from $89 and keeps an Overweight rating on the shares. Published first on ...

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its financial results for the ...

NEW YORK CITY, NY / ACCESS Newswire / November 11, 2025 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities ...